Deep venous thrombosis and thrombophilic mutations in western Iran: Association with factor v Leiden

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 5, 2010, Pages 385-388

  Rahimi, Zohreh ^a,b   Mozafari, Hadi ^a   Shahriari Ahmadi, Ali ^c   Alimogaddam, Kamran ^d   Ghavamzadeh, Ardeshir ^d   Aznab, Mozafar ^c   Mansouri, Kamran ^a   Rezaei, Mansour ^c   Parsian, Abbas ^e  

^a Medical Biology Research Center   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Deep venous thrombosis; factor V Leiden; methylenetetrahydrofolate reductase c.677C>T; prevalence; prothrombin g.20210G>A; western Iran

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; RESTRICTION ENDONUCLEASE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ETHNIC GROUP; FEMALE; GENE MUTATION; HUMAN; IRAN; LEG THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; THROMBOPHILIA;

ADULT; FACTOR V; FEMALE; HUMANS; IRAN; MALE; MUTATION; THROMBOSIS; VENOUS THROMBOSIS;

EID: 77954661369     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328330e69a     Document Type: Article

References (23)

1. Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haem 2006; 28:111-116.
2. Bezemer ID, Bare LA, Doggen CJM, Arellano AR, Tong C, Rowland CM, et al. Gene variants associated with deep vein thrombosis. JAMA 2008; 299:1306-1314.
3. Dölek B, Eraslan S, Eroglu S, Kesim BE, Ulutin T, Yalçiner A, et al. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients. Clin Appl Thromb Hemost 2007; 13:435-438.
4. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332:912-917.
5. Eichinger S, Pabinger I, Stumpflen A, Hirschl M, Bialonczyk C, Schneider B, et al. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thromb Haemost 1997; 77:624-628.
6. Cattaneo M, Chantarangkul V, Taioli E, Santos JH, Tagliabue L. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Thromb Res 1999; 93:1-8.
7. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 30-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3703.
8. Old JM, Higgs DR. Gene analysis. In: Weatherall DJ, editor. Methods in hematology. The thalassemias. Vol.6. London: Churchill Livingstone; 1983. pp. 74-101.
9. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
10. Frosst P, Blom HJ, Milos R, Goyatte P, Sheppard CA, Mathews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-113.
11. Rahimi Z, Vaisi-Raygani A, Mozafari H, Kharrazi H, Rezaei M, Nagel RL. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran. J Thromb Thrombolysis 2008; 25:280-283.
12. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85:1504-1508.
13. Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, NabulsiM, et al. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis 2005; 19:189-196.
14. Sabino AP, Guimaraes DAM, Ribeiro DD, Paiva SG, Dusse LMS, Carvalho MG, Fernandes AP. Increased factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients. J Thromb Thrombolysis 2007; 24:261-266.
15. Okumus G, Kiyan E, Arseven O, Tabak L, Diz-Kucukkaya R, Unlucerci Y, et al. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism. Clin Appl Thromb Hemost 2008; 14: 168-173.
16. Ho WH, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia. Arch Intern Med 2006; 166:729-736.
17. Altinisik J, Ates O, Ulutin T, Cengiz M, Buyru N. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients. Clin Appl Thromb Hemost 2008; 14:415-420.
18. Gonzalez-Porras JR, Garcia-Sanz R, Alberca I, Lopez ML, Balanzatequi A, Gutierrez O, et al. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. Blood Coagul Fibrinolysis 2006; 17:23-28.
19. Rintelen C, Mannhalter C, Lechner K, Eichinger S, Kyrle PA, Papagiannopoulos M, et al. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677C to T mutation in the methylene-tetrahydrofolate-reductase gene. Blood Coagul Fibrinolysis 1999; 10:101-105.
20. Cattaneo M, Tsai MY, Bucciarelli P, Taioli E, Zighetti ML, Bignell M, Manaucci PM. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506). Arterioscler Thromb Vasc Biol 1997; 17:1662-1666.
21. Kluijtmans LA, den Heijer M, Reitsma PH, Heil SG, Blom HJ, Rosendaal FR. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost 1998; 79:254-258.
22. Bezemer ID, Doggen CJM, Vos HL, Rosendaal FR. No association between the common MTHFR 677C!T polymorphism and venous thrombosis. Arch Intern Med 2007; 167:497-501.
23. Naushad S, Jamal NJ, Angalena R, Prasad CK, Devi AR. Hyperhomocysteinemia and the compound heterozygous state for methylene tetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians. Blood Coagul Fibrinolysis 2007; 18:113-117.